{"entity":{"type":"insider","cik":"0001733387","url":"/insider/0001733387","json_url":"/insider/0001733387.json","name":"Nandabalan Krishnan","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":9,"n_filings":5,"first":"2018-11-30","last":"2023-04-10","span_basis":"filed_date"},"name_variants":[{"name":"Nandabalan Krishnan","source":"filing","n_filings":5,"first_seen":"2018-11-30","last_seen":"2023-04-10"}],"transactions":[{"id":7843959,"accession":"0001104659-23-043694","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-23-043694","line_url":"/filing/0001104659-23-043694#line-2","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733387","owner_name":"Nandabalan Krishnan","owner_display_name":"Nandabalan Krishnan","owner_url":"/insider/0001733387","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":60000.0,"shares_display":"60,000","price_per_share":17.32,"price_display":"17.32","price_state":"stated","total_value":1039200.0,"total_display":"1,039,200.00","total_whole":"1,039,200","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-06","filed_date":"2023-04-10","scope":"insider"},{"id":8696938,"accession":"0001104659-23-001945","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001104659-23-001945","line_url":"/filing/0001104659-23-001945","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733387","owner_name":"Nandabalan Krishnan","owner_display_name":"Nandabalan Krishnan","owner_url":"/insider/0001733387","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25889.0,"shares_display":"25,889","price_per_share":22.338849704507705,"price_display":"22.34","price_state":"stated","total_value":578330.48,"total_display":"578,330.48","total_whole":"578,330","shares_owned_after":800.0,"shares_owned_after_display":"800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-05","filed_date":"2023-01-06","scope":"insider","n_lines":2},{"id":8696930,"accession":"0001104659-23-001945","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001104659-23-001945","line_url":"/filing/0001104659-23-001945","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733387","owner_name":"Nandabalan Krishnan","owner_display_name":"Nandabalan Krishnan","owner_url":"/insider/0001733387","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":34111.0,"shares_display":"34,111","price_per_share":21.76850605376565,"price_display":"21.77","price_state":"stated","total_value":742545.51,"total_display":"742,545.51","total_whole":"742,546","shares_owned_after":9821.0,"shares_owned_after_display":"9,821","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-04","filed_date":"2023-01-06","scope":"insider","n_lines":2},{"id":6718561,"accession":"0001104659-22-118836","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-22-118836","line_url":"/filing/0001104659-22-118836#line-4","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733387","owner_name":"Nandabalan Krishnan","owner_display_name":"Nandabalan Krishnan","owner_url":"/insider/0001733387","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32550.0,"shares_display":"32,550","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":488250.0,"total_display":"488,250.00","total_whole":"488,250","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-11","filed_date":"2022-11-14","scope":"insider"},{"id":6718557,"accession":"0001104659-22-118836","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-118836","line_url":"/filing/0001104659-22-118836#line-2","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733387","owner_name":"Nandabalan Krishnan","owner_display_name":"Nandabalan Krishnan","owner_url":"/insider/0001733387","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":27450.0,"shares_display":"27,450","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":411750.0,"total_display":"411,750.00","total_whole":"411,750","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-10","filed_date":"2022-11-14","scope":"insider"},{"id":5440975,"accession":"0001104659-21-086946","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-086946","line_url":"/filing/0001104659-21-086946#line-1","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733387","owner_name":"Nandabalan Krishnan","owner_display_name":"Nandabalan Krishnan","owner_url":"/insider/0001733387","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":473250.0,"shares_display":"473,250","price_per_share":30.8283,"price_display":"30.83","price_state":"stated","total_value":14589492.975,"total_display":"14,589,492.98","total_whole":"14,589,493","shares_owned_after":8546750.0,"shares_owned_after_display":"8,546,750","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-06-25","filed_date":"2021-06-29","scope":"insider"},{"id":6681528,"accession":"0001104659-18-070832","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-18-070832","line_url":"/filing/0001104659-18-070832#line-1","is_derivative":false,"issuer_cik":"0001720893","issuer_name":"BioXcel Therapeutics, Inc.","issuer_ticker":"BTAI","issuer_name_source":null,"issuer_url":"/issuer/0001720893","owner_cik":"0001733387","owner_name":"Nandabalan Krishnan","owner_display_name":"Nandabalan Krishnan","owner_url":"/insider/0001733387","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":4.915,"price_display":"4.92","price_state":"stated","total_value":4915.0,"total_display":"4,915.00","total_whole":"4,915","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-11-29","filed_date":"2018-11-30","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":9,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":8,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":9},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001720893","name":"BioXcel Therapeutics, Inc.","url":"/issuer/0001720893","role":"Director, Ten percent owner","n_filings":5,"first_seen":"2018-11-30","last_seen":"2023-04-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001733387","retrieved_at":"2026-08-26T07:39:37+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}